CLL cells silenced for NF-κB-p65 also were not induced by Wnt5a to express higher levels of MMP-9, in contrast to the CLL cells treated with the control siRNA. The gene discussed is NFKB1; the disease is B-cell chronic lymphocytic leukemia.